EV/EBITDA
-1.54
0.000.00%
Thu, 06 Mar 2025 00:47:44 GMT
Summary
- As of March 6, 2025, NRXP EV/EBITDA is -1.54, unchanged from the previous trading day.
- Over the past year, NRXP EV/EBITDA has increased by +0.75 (+32.75%).
- NRXP EV/EBITDA is now -2300.00% below its all-time high of 0.07.
Performance
NRXP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NRXP EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | 0.0% | 0.0% | 0.0% |
1 m1 month | +29.7% | -29.7% | -33.5% |
3 m3 months | -54.0% | +53.4% | +71.2% |
6 m6 months | -58.8% | +29.8% | +27.4% |
ytdytd | -2.7% | +2.8% | +3.4% |
1 y1 year | +32.8% | -55.1% | -69.5% |
5 y5 years | - | - | -98.0% |
NRXP EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -4.0% | -2.19 | +29.7% | |
3 m | 3-month | -0.96 | -60.4% | -3.23 | +52.3% |
6 m | 6-month | -0.91 | -69.2% | -3.23 | +52.3% |
1 y | 1-year | -0.91 | -69.2% | -3.23 | +52.3% |
3 y | 3-year | 0.07 | -2300.0% | -3.23 | +52.3% |
5 y | 5-year | 0.07 | -2300.0% | -15.70 | +90.2% |
alltime | all time | 0.07 | -2300.0% | -15.70 | +90.2% |
NRx Pharmaceuticals EV/EBITDA History
Date | Value |
---|---|
2025 | -1.54(+2.7%) |
2024 | -1.50(+4.2%) |
Date | Value |
---|---|
2023 | -1.44(-11.1%) |
2022 | -1.62(-40.7%) |
2021 | -2.73 |
FAQ
- What is NRx Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for NRx Pharmaceuticals?
- What is NRXP EV/EBITDA year-to-date change?
- What is NRx Pharmaceuticals EV/EBITDA year-on-year change?
What is NRx Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of NRXP is -1.54
What is the all time high EV/EBITDA for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high EV/EBITDA is 0.07
What is NRXP EV/EBITDA year-to-date change?
NRx Pharmaceuticals EV/EBITDA has changed by -0.04 (-2.67%) since the beginning of the year
What is NRx Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, NRXP EV/EBITDA has changed by +0.75 (+32.75%)